Author

Daniel C. Baumgart 1

1 University of Alberta,Edmonton,Canada

CLOSTRIDIUM DIFFICILE INFECTION IN PATIENTS TREATED WITH TOFACITINIB IN THE ULCERATIVE COLITIS CLINICAL PROGRAMME

Daniel C. Baumgart, Chinyu Su, Kenneth Kwok, Jami A. Kinnucan, Xiang Guo, Susan B. Connelly, Edward V. Loftus Jr., Krisztina B. Gecse, Alessandro Armuzzi

CLOSTRIDIUM DIFFICILE INFECTION IN PATIENTS WITH ULCERATIVE COLITIS TREATED WITH TOFACITINIB IN THE ULCERATIVE COLITIS PROGRAMME: AN UPDATE AS OF MAY 2019

Edward V Loftus Jr., Alessandro Armuzzi, Daniel C. Baumgart, Jeffrey R Curtis, Jami A. Kinnucan, Nana Koram, Leonardo Salese, Chinyu Su, Kenneth Kwok, John Woolcott

ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications

Christian Maaser, Andreas Sturm, Stephan Vavricka, Torsten Kucharzik, Gionata Fiorino, Vito Annese, Emma Calabrese, Daniel C. Baumgart, Dominik Bettenworth, Paula Borralho-Nunes, Johan Burisch, Fabiana Castiglione, Abraham (Rami) Eliakim, Pierre Ellul, Iago González Lama, Hannah Gordon, Steve Halligan, Konstantinos H. Kats

ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects

Andreas Sturm, Christian Maaser, Emma Calabrese, Vito Annese, Gionata Fiorino, Torsten Kucharzik, Stephan Vavricka, Bram Verstockt, Patrick Van Rheenen, Damian Tolan, Stuart Taylor, Jordi Rimola, Florian Rieder, Jimmy K. Limdi, Andrea Laghi, Eduards Krustins, Paulo Gustavo Kotze, Uri Kopylov, Konstantinos H. Katsanos, St

EFFICACY AND SAFETY OF THE NOVEL 1L PEG AND ASCORBATE BOWEL PREPARATION NER1006 VERSUS SODIUM PICOSULFATE + MAGNESIUM CITRATE IN DAY BEFORE SPLIT-DOSING ADMINISTRATION: RESULTS FROM THE PHASE 3 STUDY DAYB

Stefan Schreiber, Daniel C. Baumgart, Joost P.H. Drenth, Rafał Filip, Lucy B Clayton, Richard Ng Kwet Shing, Cesare Hassan

FREQUENCY, TYPE AND OUTCOME OF REPORTED SIDE EFFECTS AND ADVERSE EVENTS OF NON-BIOLOGIC DRUGS USED IN INFLAMMATORY BOWEL DISEASE: A NATIONWIDE COHORT STUDY USING THE GERMAN FEDERAL INSTITUTE FOR DRUGS AND MEDICAL DEVICES (BFARM) PHARMACOVIGILANCE DATABASE

Daniel C. Baumgart, Ulrike Grittner

INCREASED EXPRESSION OF T-CELL-ASSOCIATED GENES IN BASELINE BIOPSIES FROM TNF ANTAGONIST NAIVE PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS WHO UNDERGO REMISSION IN RESPONSE TO ETROLIZUMAB IN A PHASE II TRIAL

Gaik Tew, Jason Hackney, Deena Gibbons, Christopher Andrew Lamb, Diana Luca, Jackson Egen, Severine Vermeire, John Charles Mansfield, Brian G. Feagan, Julian Panés, Daniel C. Baumgart, Stefan Schreiber, Iris Dotan, William Sandborn, John A. Kirby, Peter Irving, Gert De Hertogh, Gert Van Assche, Paul Rutgeerts, Sharon O'B

LONG-TERM TREATMENT WITH FERRIC MALTOL IS EFFECTIVE AND WELL TOLERATED IN CORRECTING IRON DEFICIENCY ANEMIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: RESULTS FROM A PHASE-3 OPEN-LABEL STUDY

Carsten Schmidt, Tariq Ahmad, Zsolt Tulassay, Daniel C. Baumgart, Bernd Bokemeyer, Stefanie Howaldt, Andreas Stallmach, Carsten Büning

PHARMACOLOGY OF ETROLIZUMAB IN A PHASE 2 STUDY IN MODERATE TO SEVERELY ACTIVE ULCERATIVE COLITIS

Marna Williams, Mary E. Keir, Caroline Looney, Franklin Fuh, Wei Tew, Kathleen Howell, Sha Klabunde, Clarissa Johnson, Xiaohui Wei, Meina Tang, Diana Luca, Azucena Salas, Severine Vermeire, Clementine Perrier, Julian Panés, Daniel C. Baumgart, John Charles Mansfield, Maren Paulsen, Philip Rosenstiel, Stefan Schreiber, I

PHARMACOLOGY OF ETROLIZUMAB IN A PHASE 2 STUDY IN MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

Caroline Looney, Franklin Fuh, Meina Tang, Xiaohui Wei, Mary E. Keir, Gaik Tew, Jeffrey Eastham-Anderson, Lauri Diehl, Azucena Salas, Gert De Hertogh, Steven Francom, Houston Gilbert, Diana Luca, Jackson Egan, Severine Vermeire, John Charles Mansfield, Christopher Andrew Lamb, Brian G. Feagan, Julian Panés, Daniel C. Bau

Item 1 - 10 / 29
1
2 3